David Busse

804 total citations
24 papers, 515 citations indexed

About

David Busse is a scholar working on Pharmacology, Clinical Psychology and Behavioral Neuroscience. According to data from OpenAlex, David Busse has authored 24 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Clinical Psychology and 6 papers in Behavioral Neuroscience. Recurrent topics in David Busse's work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Stress Responses and Cortisol (6 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). David Busse is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (9 papers), Stress Responses and Cortisol (6 papers) and Child and Adolescent Psychosocial and Emotional Development (4 papers). David Busse collaborates with scholars based in Germany, United States and Austria. David Busse's co-authors include Ilona S. Yim, Belinda Campos, Barbara E. McDermott, Cameron Quanbeck, Charles L. Scott, Christopher K. Marshburn, John F. Edens, Charlotte Kloft, Christoph Dorn and Hermann Wrigge and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

David Busse

22 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Busse Germany	14	234	180	127	61	59	24	515
Rania Itani Lebanon	11	44 0.2×	28 0.2×	40 0.3×	13 0.2×	19 0.3×	35	415
Samar Karout Lebanon	11	44 0.2×	19 0.1×	39 0.3×	13 0.2×	19 0.3×	25	402
Kim Corace Canada	12	51 0.2×	46 0.3×	42 0.3×	3 0.0×	26 0.4×	25	353
Mariola Drozd Poland	9	76 0.3×	34 0.2×	30 0.2×	4 0.1×	50 0.8×	42	730
Farnoosh Moafi Iran	9	67 0.3×	48 0.3×	18 0.1×	18 0.3×	34 0.6×	23	424
Joyce Frye United States	11	177 0.8×	17 0.1×	21 0.2×	7 0.1×	19 0.3×	17	449
Ebrahim Mahmoud Saudi Arabia	8	260 1.1×	12 0.1×	31 0.2×	6 0.1×	63 1.1×	19	553
Rachel Brathwaite United States	15	130 0.6×	38 0.2×	44 0.3×	4 0.1×	41 0.7×	45	552
Ruth C. Bindler United States	15	85 0.4×	40 0.2×	15 0.1×	14 0.2×	33 0.6×	38	711
Nawarat Suwannapong Thailand	14	40 0.2×	35 0.2×	21 0.2×	9 0.1×	14 0.2×	32	530

Countries citing papers authored by David Busse

Since Specialization

Citations

This map shows the geographic impact of David Busse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Busse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Busse more than expected).

Fields of papers citing papers by David Busse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Busse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Busse. The network helps show where David Busse may publish in the future.

Co-authorship network of co-authors of David Busse

This figure shows the co-authorship network connecting the top 25 collaborators of David Busse. A scholar is included among the top collaborators of David Busse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Busse. David Busse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, Philipp, David Busse, Robin Michelet, et al.. (2025). Evaluation of the need for dosing adaptations in obese patients for surgical antibiotic prophylaxis: a model-based analysis of cefazolin pharmacokinetics. British Journal of Anaesthesia. 134(4). 1041–1049. 2 indexed citations

Michelet, Robin, et al.. (2024). A minimal physiologically‐based pharmacokinetic modeling platform to predict intratumor exposure and receptor occupancy of an anti‐LAG‐3 monoclonal antibody. CPT Pharmacometrics & Systems Pharmacology. 14(3). 460–473.

Busse, David, Philipp Simon, David Petroff, et al.. (2022). High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients. Antimicrobial Agents and Chemotherapy. 66(6). e0230221–e0230221. 5 indexed citations

Busse, David, Philipp Simon, David Petroff, et al.. (2021). Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients. Clinical Pharmacokinetics. 61(5). 655–672. 10 indexed citations

Busse, David, Philipp Simon, David Petroff, et al.. (2021). Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics. Pharmaceutics. 13(9). 1380–1380. 8 indexed citations

Busse, David, Alexander Solms, Robin Michelet, et al.. (2021). Which Analysis Approach Is Adequate to Leverage Clinical Microdialysis Data? A Quantitative Comparison to Investigate Exposure and Response Exemplified by Levofloxacin. Pharmaceutical Research. 38(3). 381–395. 10 indexed citations

Busse, David, Jens Markus Borghardt, David Petroff, et al.. (2021). Evaluating prediction methods for glomerular filtration to optimise drug doses in obese and nonobese patients. British Journal of Clinical Pharmacology. 88(6). 2973–2981. 8 indexed citations

Simon, Philipp, David Busse, David Petroff, et al.. (2020). Risk of target non-attainment in obese compared to non-obese patients in calculated linezolid therapy. Clinical Microbiology and Infection. 26(9). 1222–1228. 30 indexed citations

Busse, David, Philipp Simon, Robin Michelet, et al.. (2020). Quantification of microdialysis related variability in humans: Clinical trial design recommendations. European Journal of Pharmaceutical Sciences. 157. 105607–105607. 14 indexed citations

10.

Grensemann, Jörn, David Busse, Christina König, et al.. (2020). Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study. Annals of Intensive Care. 10(1). 48–48. 21 indexed citations

11.

Busse, David, et al.. (2020). Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation. Journal of Pharmaceutical Sciences. 109(7). 2309–2320. 11 indexed citations

12.

Simon, Philipp, David Busse, David Petroff, et al.. (2020). Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study. Journal of Clinical Medicine. 9(4). 1067–1067. 16 indexed citations

13.

Kofman, Yasmin B., David Busse, Belinda Campos, et al.. (2019). Cortisol reactivity and depressive symptoms in pregnancy: The moderating role of perceived social support and neuroticism. Biological Psychology. 147. 107656–107656. 31 indexed citations

14.

Busse, David, Weifeng Tang, Markus F. Scheerer, et al.. (2019). Comparison of pharmacokinetics and the exposure–response relationship of dapagliflozin between adolescent/young adult and adult patients with type 1 diabetes mellitus. British Journal of Clinical Pharmacology. 85(8). 1820–1828. 11 indexed citations

15.

Busse, David, Ilona S. Yim, & Belinda Campos. (2017). Social context matters: Ethnicity, discrimination and stress reactivity. Psychoneuroendocrinology. 83. 187–193. 31 indexed citations

16.

Busse, David, Ilona S. Yim, Belinda Campos, & Christopher K. Marshburn. (2017). Discrimination and the HPA axis: current evidence and future directions. Journal of Behavioral Medicine. 40(4). 539–552. 90 indexed citations

17.

Campos, Belinda, et al.. (2014). Are the costs of neuroticism inevitable? Evidence of attenuated effects in U.S. Latinas.. Cultural Diversity & Ethnic Minority Psychology. 20(3). 430–440. 15 indexed citations

18.

McDermott, Barbara E., et al.. (2008). The conditional release of insanity acquittees: three decades of decision-making.. PubMed. 36(3). 329–36. 30 indexed citations

19.

McDermott, Barbara E., et al.. (2008). The accuracy of risk assessment instruments in the prediction of impulsive versus predatory aggression. Behavioral Sciences & the Law. 26(6). 759–777. 40 indexed citations

20.

McDermott, Barbara E., John F. Edens, Cameron Quanbeck, David Busse, & Charles L. Scott. (2007). Examining the role of static and dynamic risk factors in the prediction of inpatient violence: Variable- and person-focused analyses.. Law and Human Behavior. 32(4). 325–338. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact